ALEXANDRIA, Va., June 4 -- United States Patent no. 12,319,685, issued on June 3, was assigned to H. LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE INC. (Tampa, Fla.).

"Small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors" was invented by Alan List (Tampa, Fla.) and Haitao Ji (Tampa, Fla.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are small molecule pyrin-domain targeted NLRP3 inflammasome inhibitors."

The patent was filed on Aug. 15, 2019, under Application No. 17/268,983.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&...